Current and emerging therapies for the treatment of pancreatic cancer.

Onco Targets Ther · 2010 · PMC2939765 · PMID 20856847

Europe PMC DOI

hedged sentence

0.2080

closest p · 4.2× alpha

0.2080

boldest claim

The sentences

did not reach statistical significanceP = 0.208not close (p > 0.1)

The median duration of survival was 19.0 months for the observation group and 24.5 months in the treatment group but the study did not reach statistical significance (two-tailed test, P = 0.208). 16 Thus, CRT did not become standard practice in Europe.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.